Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24 2015 - 4:05PM
GAITHERSBURG, Md., Nov. 24, 2015
(GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage
vaccine company focused on the discovery, development and
commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that Stanley C. Erck, President and CEO,
will present at the 27th Annual
Piper Jaffray Healthcare Conference.
Conference details are as
follows:
Date: Tuesday, December 1,
2015
Time: 2:00 p.m. U.S. Eastern Time
Location: New York Palace Hotel, New York City
Live webcast: http://edge.media-server.com/m/p/ui3ne8dn
The webcast and a replay of the
presentation will also be accessible under the "Investors/Events"
section of the Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage vaccine company committed to delivering novel
products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the Company's
website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1969132
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Oct 2023 to Oct 2024